What Should Physician-Researchers Tell Patient-Subjects About Their Relationships With Industry?
An investigator's personal financial interest in technology under investigation or in the company sponsoring the research is a clear conflict of interest (COI). Such financial relationships are common, and ethical questions rightly emerge about COIs' capacity to compromise an investigator's approach...
| Publicado en: | AMA Journal of Ethics Vol. 23; no. 9; pp. 685 - 692 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
American Medical Association
Sep2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=152240097&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 152240097 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 23766980 IT3R jtl: AMA Journal of Ethics issn: 23766980 maglogo: N pubinfo: dt: Sep2021 vid: 23 iid: 9 pid: 10281 pub: American Medical Association place: Chicago, Illinois artinfo: ui: 152240097 10.1001/amajethics.2021.685 152240097 ppf: 685 ppct: 7 formats: tig: atl: What Should Physician-Researchers Tell Patient-Subjects About Their Relationships With Industry? aug: au: Botkin, Jeffrey R. affil: Professor of pediatrics at the University of Utah in Salt Lake City, where he is also the former associate vice president for research integrity sug: subj: Conflict of Interest (Research) Researcher-Subject Relations Consent (Research) Physician Researchers Decision Making ab: An investigator's personal financial interest in technology under investigation or in the company sponsoring the research is a clear conflict of interest (COI). Such financial relationships are common, and ethical questions rightly emerge about COIs' capacity to compromise an investigator's approaches to research. This commentary on a case suggests that COI disclosure is appropriate during the process of facilitating patient-subjects' informed consent because it promotes informed decision making and motivates transparency. But COI disclosures are not always efficacious, nor are they sufficient to address the problem of research bias. This commentary argues that mitigation or elimination of COIs is a more effective strategy than disclosure. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|